Stockscreener 앱 받기
1.25
5.34%
-0.06
시간 외 거래:
1.29
0.04
+3.20%
전일 마감가:
$1.31
열려 있는:
$1.33
하루 거래량:
110.88K
Relative Volume:
0.68
시가총액:
$14.47M
수익:
$996.00K
순이익/손실:
$-6.09M
주가수익비율:
-2.3585
EPS:
-0.53
순현금흐름:
$-9.76M
1주 성능:
+5.98%
1개월 성능:
+15.89%
6개월 성능:
+1.64%
1년 성능:
-20.77%
1일 변동 폭
$1.20
$1.3399
1주일 범위
$1.15
$1.37
52주 변동 폭
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
명칭
Therapeuticsmd Inc
전화
561-961-1900
주소
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
TXMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.25 | 15.16M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
145.43 | 65.38B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.11 | 44.75B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.10 | 40.97B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.79 | 22.50B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
415.34 | 19.04B | 3.08B | 1.24B | 1.07B | 25.61 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-08-07 | 다운그레이드 | Jefferies | Hold → Underperform |
| 2020-05-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-12-02 | 개시 | Guggenheim | Buy |
| 2019-10-17 | 개시 | H.C. Wainwright | Buy |
| 2019-04-30 | 재개 | Noble Capital Markets | Outperform |
| 2018-06-15 | 개시 | JP Morgan | Overweight |
| 2017-09-08 | 개시 | Morgan Stanley | Equal-Weight |
| 2017-07-11 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2017-05-09 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2016-11-22 | 재개 | Jefferies | Buy |
| 2016-11-22 | 개시 | Oppenheimer | Outperform |
| 2016-11-07 | 재개 | Guggenheim | Buy |
| 2016-04-04 | 개시 | Goldman | Buy |
| 2015-12-08 | 재확인 | Jefferies | Buy |
| 2015-12-08 | 재확인 | Stifel | Buy |
| 2015-09-21 | 재확인 | Jefferies | Buy |
| 2015-06-09 | 개시 | Guggenheim | Buy |
| 2014-07-08 | 개시 | FBR Capital | Outperform |
| 2014-04-17 | 재확인 | Noble Financial | Buy |
| 2014-01-28 | 재확인 | Noble Financial | Buy |
모두보기
Therapeuticsmd Inc 주식(TXMD)의 최신 뉴스
How TherapeuticsMD Inc. (29TA) stock correlates with oil marketsSwing Trade & Accurate Intraday Trading Signals - newser.com
Why TherapeuticsMD Inc. stock remains a top recommendationQuarterly Earnings Report & Technical Entry and Exit Alerts - newser.com
Can TherapeuticsMD Inc. stock surprise with earnings upside2025 Growth vs Value & AI Enhanced Trading Signals - newser.com
What MACD and RSI say about TherapeuticsMD Inc.2025 Performance Recap & AI Powered Buy/Sell Recommendations - newser.com
Can a trend reversal in TherapeuticsMD Inc. lead to recoveryInflation Watch & Real-Time Buy Signal Alerts - newser.com
Why TherapeuticsMD Inc. stock is seen as undervalued2025 Analyst Calls & Reliable Volume Spike Alerts - newser.com
Key metrics from TherapeuticsMD Inc.’s quarterly dataJuly 2025 WrapUp & Verified Chart Pattern Trade Signals - newser.com
Will TherapeuticsMD Inc. stock benefit from upcoming earnings reportsMarket Trend Summary & Risk Managed Investment Signals - newser.com
How to build a dashboard for TherapeuticsMD Inc. stockWeekly Earnings Recap & Weekly Top Gainers Trade List - newser.com
Why ETFs are accumulating TherapeuticsMD Inc. (29TA) stockDay Trade & AI Enhanced Execution Alerts - newser.com
How to read the order book for TherapeuticsMD Inc.Earnings Miss & Real-Time Volume Triggers - newser.com
Why Jiayin Group Inc. Depositary Receipt stock attracts strong analyst attention - newser.com
Therapeuticsmd Inc (TXMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Therapeuticsmd Inc 주식 (TXMD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
| Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
| Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
| Collins Cooper C. | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
60,516 |
| Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
| Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
| Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
1.87%
0.79%
자본화:
|
볼륨(24시간):